Compounds > methionine
Page last updated: 2024-08-17

methionine and Substance Withdrawal Syndrome

methionine has been researched along with Substance Withdrawal Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rehni, AK; Singh, TG1
Gelernter, J; Herman, AI; Jatlow, PI; Listman, JB; Sofuoglu, M1
Arora, SK; Rehni, AK; Singh, TG1
Anastasia, A; Blendy, JA; Hempstead, BL; Lee, BG; Lee, FS1
Besser, GM; Clement-Jones, V; Lowry, PJ; McLoughlin, L; Rees, LH; Wen, HL1
Hughes, J1
Havlicek, V; LaBella, FS; Leybin, L; Pinsky, C; Rezek, M1

Other Studies

7 other study(ies) available for methionine and Substance Withdrawal Syndrome

ArticleYear
Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro.
    Neuropharmacology, 2013, Volume: 71

    Topics: Alkyl and Aryl Transferases; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Female; Ileum; Imidazoles; In Vitro Techniques; Leucine; Male; Methionine; Mice; Morphine Dependence; Muscle Contraction; Muscle, Smooth; Naphthalenes; Rats; Rats, Wistar; Substance Withdrawal Syndrome

2013
COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokers.
    The pharmacogenomics journal, 2013, Volume: 13, Issue:6

    Topics: Catechol O-Methyltransferase; Cognition; Humans; Infusions, Intravenous; Methionine; Nicotine; Smoking; Substance Withdrawal Syndrome; Valine

2013
Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
    Behavioural pharmacology, 2013, Volume: 24, Issue:8

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Male; Mecamylamine; Methionine; Mice; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome

2013
Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015, Volume: 17, Issue:12

    Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Female; Gene Knock-In Techniques; Male; Methionine; Mice; Mice, Transgenic; Nicotine; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome; Tobacco Use Disorder; Valine

2015
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid.
    Lancet (London, England), 1979, Aug-25, Volume: 2, Issue:8139

    Topics: Acupuncture Therapy; Adrenocorticotropic Hormone; Adult; Antigens; beta-Lipotropin; Endorphins; Enkephalins; Heroin Dependence; Humans; Hydrocortisone; Male; Methionine; Middle Aged; Substance Withdrawal Syndrome

1979
Enkephalin and drug dependence.
    The British journal of addiction to alcohol and other drugs, 1976, Volume: 71, Issue:3

    Topics: Animals; beta-Lipotropin; Chemical Phenomena; Chemistry; Heroin Dependence; Humans; Leucine; Ligands; Methionine; Neural Inhibition; Peptides; Receptors, Opioid; Substance Withdrawal Syndrome

1976
Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats.
    Nature, 1976, Dec-02, Volume: 264, Issue:5585

    Topics: Animals; Humans; Injections, Intraventricular; Leucine; Male; Methionine; Morphine; Nerve Tissue Proteins; Oligopeptides; Pain; Rats; Receptors, Opioid; Structure-Activity Relationship; Substance Withdrawal Syndrome

1976